Aug 09 2012 The burgeoning U.S. stem cell therapy industry was delivered a setback last month in the form of a U.S. District Court injunction against use of the Regenexx Procedure, which purports to treat joint, muscle, tendon or bone pain due to injury or other conditions.
FULL ARTICLE AT Science-Based Medicine